Get the Stockscreener App
26.97
0.55%
-0.15
After Hours:
26.98
0.01
+0.04%
Eton Pharmaceuticals Inc stock is traded at $26.97, with a volume of 353.03K.
It is down -0.55% in the last 24 hours and up +42.47% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$27.12
Open:
$27.1
24h Volume:
353.03K
Relative Volume:
1.04
Market Cap:
$735.86M
Revenue:
$79.95M
Net Income/Loss:
$-4.60M
P/E Ratio:
-150.92
EPS:
-0.1787
Net Cash Flow:
$10.19M
1W Performance:
+2.18%
1M Performance:
+42.47%
6M Performance:
+40.84%
1Y Performance:
+90.06%
1-Day Range:
$26.80
$27.29
1-Week Range:
$25.34
$27.29
52-Week Range:
$13.09
$27.29
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
26.97 | 739.96M | 79.95M | -4.60M | 10.19M | -0.1787 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
120.76 | 50.93B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.66 | 43.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.61 | 36.99B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
577.58 | 25.36B | 3.18B | 1.33B | 1.04B | 27.90 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 1-Year HighTime to Buy? - MarketBeat
Eton Pharmaceuticals (ETON) price target increased by 25.56% to 38.42 - MSN
April 2026's Top Growth Companies With Strong Insider Ownership - Yahoo Finance UK
Chart Watch: Why is Eton Pharmaceuticals Inc stock going downTrade Risk Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Value Recap: Can Eton Pharmaceuticals Inc maintain sales growth2026 Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Stop Loss: Can Eton Pharmaceuticals Inc lead its sector in growth2026 Key Highlights & Fast Entry High Yield Tips - baoquankhu1.vn
Exit Recap: Can Eton Pharmaceuticals Inc maintain sales growth2026 Sentiment & Daily Profit Maximizing Tips - baoquankhu1.vn
Risk Recap: What is the PEG ratio of Eton Pharmaceuticals Inc2026 Winners & Losers & Daily Stock Trend Watchlist - baoquankhu1.vn
ETON Stock Price, Quote & Chart | ETON PHARMACEUTICALS INC (NASDAQ:ETON) - ChartMill
Profit Review: Is Eton Pharmaceuticals Inc a cyclical or defensive stock2026 Opening Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Eton Pharmaceuticals (NASDAQ:ETON) Hits New 1-Year HighTime to Buy? - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability - Moomoo
Eton Pharmaceuticals, Inc. (ETON) stock price, news, quote and history - Yahoo Finance UK
How The Eton Pharmaceuticals (ETON) Story Is Shifting With Hemangeol And New Valuation Targets - Yahoo Finance
(ETON) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Eton Pharmaceuticals Inc (ETON) Stock Price, Quote, News & History - Benzinga
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Eton Pharmaceuticals (ETON) soars 6.7%: Is further upside left in the stock? - MSN
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week HighHere's Why - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 14.4% in March - MarketBeat
JPMorgan Chase & Co. Has $7.64 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Layoff Watch: Can Eton Pharmaceuticals Inc maintain sales growth2026 Big Picture & Community Verified Trade Alerts - baoquankhu1.vn
Breakout Move: Is Eton Pharmaceuticals Inc forming a breakout patternMarket Activity Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
The Insider Report: Markets Wade into Geopolitical Abyss - Benzinga
Vanguard (ETON) Disaggregates Holdings, Reports 0 Shares - Stock Titan
Eton Pharmaceuticals (ETON) Jumps 6.7%: Does the Stock Have More Room to Grow? - Bitget
Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Does Eton Pharmaceuticals (ETON) have the potential to rally 49.25% as Wall Street analysts expect? - MSN
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week High After Analyst Upgrade - MarketBeat
Recent price trend in Eton Pharmaceuticals (ETON) is your friend, here's why - MSN
H.C. Wainwright raises Eton Pharmaceuticals price target on growth goals By Investing.com - Investing.com Canada
Dow Update: Is Eton Pharmaceuticals Inc still a buy after recent gainsMarket Performance Report & Consistent Income Trade Recommendations - baoquankhu1.vn
Zacks Research Upgrades Eton Pharmaceuticals (NASDAQ:ETON) to Strong-Buy - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Rating Increased to Buy at Wall Street Zen - MarketBeat
Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path - TipRanks
Eton Pharmaceuticals receives Investment Bank Analyst Rating Update By Investing.com - Investing.com Canada
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
B. Riley Financial Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - MarketBeat
Craig Hallum Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect? - sharewise.com
Does Eton Pharmaceuticals (ETON) Have a Chance to Surge 49.25% According to Wall Street Analysts' Predictions? - Bitget
B.Riley raises Eton Pharmaceuticals stock price target on strong Q4 results - Investing.com Canada
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript - Insider Monkey
Eton Pharma 2025 Financial Results & 2026 Outlook | Product Launches Drive GrowthNews and Statistics - IndexBox
Portfolio Update: Can Eton Pharmaceuticals Inc. lead its sector in growth2026 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Eton Pharmaceuticals 2023 Financial Results: Revenue, Net Income, and Key Financial Highlights - Minichart
Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals 2025 Annual Report: Rare Disease Drug Portfolio, Regulatory Pathways, and Risk Factors Overview - Minichart
Is Eton Pharmaceuticals Inc a cyclical or defensive stock2026 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Eton Pharmaceuticals, Inc. (ETON) Q4 earnings lag estimates - MSN
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):